Mr. Anutin Charnvirakul, Thailand’s Deputy Prime Minister and Minister of Public Health, actively supports the promotion and safe treatment of medical cannabis. Studies have revealed that cannabis has the potential to effectively treat various diseases, including cancer, epilepsy, multiple sclerosis, muscle pain, and neuralgia. Recognizing the impact of COVID-19 on the Thai economy, Mr. Charnvirakul highlights the need for economic reform and new opportunities. The government aims to position Thailand as a comprehensive medical hub in Asia, actively encouraging the development of the cannabis value chain, including cultivation, standardization, market expansion, and support for investments in new products. The medical industry offers significant promise for economic reform, with a global valuation of around US$8.3 trillion. The legalized cannabis market is valued at approximately US$12.5 billion, according to the World Health Organization and Prohibition Partners. Thailand has the potential to seize this opportunity due to its abundant resources, skilled personnel, and infrastructure. Thailand seeks to establish itself as a hub for medical and wellness tourism, attracting individuals who prefer integrative medicine and plant-based products, especially those derived from herbs for cancer and seizure patients. These products, including cosmetics and dietary supplements, can also contribute value to the food and drink market. This holistic approach benefits patients, farmers, and entrepreneurs by promoting the cultivation and development of sustainable products. To drive this vision forward, the Thai government has facilitated a partnership between the public and private sectors, resulting in the establishment of the International Medical Cannabis Research Center. This collaboration was formalized through a memorandum of understanding (MOU) with RxLeaf World Medica Company Limited, a subsidiary of Amara Asia Company Limited. Amara Asia has extensive expertise in cannabis cultivation and utilizes solvent-free technology for medical purposes. This partnership ensures the convergence of knowledge and resources, leading to groundbreaking research and innovation in the field of medical cannabis. With the support of government initiatives, private sector collaboration, and the expertise of companies like Amara Asia, Thailand is set to become a leader in the medical cannabis industry. This transformative opportunity offers not only potential economic benefits but also the ability to provide holistic and innovative healthcare solutions. By embracing the challenge and capitalizing on its strengths, Thailand is positioning itself as a trailblazer in the realm of medical cannabis, ready to make a significant impact on the well-being of its citizens and the global community.

Vicann Thailand has been granted a license to establish the first medical cannabis cultivation center in Thailand ¹. The license was granted on November 21, 2023 ¹.

This is a significant milestone for Thailand’s medical cannabis industry, which has been expanding since the legalization of medical cannabis in 2018 ². The new cultivation center will enable the production of high-quality medical cannabis products, which can be used to treat various diseases such as cancer, epilepsy, multiple sclerosis with muscle pain, and neuralgia ¹.

It is worth noting that the news article you provided was published on November 21, 2023 ¹.

Learn more:

1. prnewswire.com2. cannabisnow.com3. cannabistraininguniversity.com4. amaraasia.com5. amaraasia.com